Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 -- 965 2022-07-15 09:18:23 |
2 Format correction + 42 word(s) 1007 2022-07-15 09:44:29 |

Video Upload Options

Do you have a full video?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Belhout, C. Antimicrobial Resistance of Staphylococci. Encyclopedia. Available online: https://encyclopedia.pub/entry/25176 (accessed on 16 May 2024).
Belhout C. Antimicrobial Resistance of Staphylococci. Encyclopedia. Available at: https://encyclopedia.pub/entry/25176. Accessed May 16, 2024.
Belhout, Chahrazed. "Antimicrobial Resistance of Staphylococci" Encyclopedia, https://encyclopedia.pub/entry/25176 (accessed May 16, 2024).
Belhout, C. (2022, July 15). Antimicrobial Resistance of Staphylococci. In Encyclopedia. https://encyclopedia.pub/entry/25176
Belhout, Chahrazed. "Antimicrobial Resistance of Staphylococci." Encyclopedia. Web. 15 July, 2022.
Antimicrobial Resistance of Staphylococci
Edit

Staphylococci are present in the microbiota of both humans and animal species, being recognized as the most important opportunistic pathogens. Antimicrobial resistance (AMR) has become a global public health issue presenting a significant risk because it severely limits treatment options. Methicillin resistance in staphylococci (MRS) poses a specific problem as it may cause serious human and animal infections, eventually resulting in death. 

Staphylococci methicillin-resistant staphylococci (MRS) methicillin-resistant S. aureus (MRSA)

1. Introduction

The genus Staphylococcus is currently composed of more than 84 recognized species and 30 subspecies [1]. Recently the genus has been reassessed and some species have been transferred to a new genus, Mammaliicoccus, which contains 5 former Staphylococcus species (Table 1) [2]Staphylococcus sciuriStaphylococcus fleurettiiStaphylococcus lentusStaphylococcus stepanovicii and Staphylococcus vitulinus have been transferred to the novel genus Mammaliicoccus with Mammaliicoccus sciuri as the type species [2]. The staphylococci are divided into two distinct groups: the coagulase-positive staphylococci (CPS), such as Staphylococcus aureus and six other species, and the coagulase-negative staphylococci (CNS) [2][3]. They generally are part of the normal flora of mammals and birds [4], though, upon predisposing factors, they can cause mild to serious life-threatening diseases [5]. Some species are recognized as human and facultative animal pathogens, especially the coagulase-positive species though also some coagulase-negative species such as Staphylococcus epidermidisStaphylococcus haemolyticusStaphylococcus lugdunensis, and Staphylococcus saprophyticus are well known facultative pathogens [6][7], generally implicated in nosocomial infections [8].
Table 1. Recent reclassification of members of the genus Staphylococcus (Adapted from [2]).

2. Antimicrobial Resistance of Staphylococci

Antimicrobial resistance (AMR) has become a global public health issue, presenting a significant risk because it severely limits treatment options. Almost all countries, irrespective of their wealth, are facing this threat [9][10]. Methicillin-resistant staphylococci (MRS) pose a specific problem, as they may cause serious human and animal infections, eventually resulting in death [11]. Methicillin-resistant S. aureus (MRSA) emerged within two years after the introduction of staphylococcal beta-lactamases resistant beta-lactams, with methicillin being the first introduced [12]. Acquisition of methicillin resistance is due to integration of the staphylococcal cassette chromosome mec (SCCmec), which contains the mecA gene conferring resistance to β-lactams [13]. In 2011, A divergent mecA homologue, mecALGA251, later named mecC, was discovered and located in a novel staphylococcal cassette chromosome mec element, designated SCCmec type-XI [14]. The mecC was 70% identical to the mecA gene and was initially detected in 15 S. aureus isolates from dairy cattle in England [14].
Apart from S. aureus, methicillin resistance has also been discovered in many staphylococci and are named methicillin-resistant non-aureus staphylococci (MRNaS) [15][16][17]. MRNaS have been isolated from humans [18] and animals [17][19], and are proposed to be a potential reservoir of SCCmec elements for S. aureus [20].
The infections caused by MRSA were initially confined to hospitals and healthcare facilities and were named hospital-acquired MRSA (HA-MRSA), with sporadic infections in the community related to direct exposure to the healthcare system [21]. During the mid-1990s, new MRSA lineages emerged, which were, in general, quite susceptible to different antimicrobials and possessed the SCCmecIV [22]. The first infections with these new clones were found in native people in Australia and North America, as well as in people involved in contact sports [23]. These strains spread in the community and were likewise named community-acquired MRSA (CA-MRSA) [24]. During their evolution, they became dominant in hospitals [25]. In 2005, a new MSRA clone, ST398, was found in livestock [26], and was subsequently named LA-MRSA [27]. This clone was shown to have originated from humans and seemed to have lost host specificity while acquiring methicillin resistance [28]. Further studies showed the increasing diversity of LA-MRSA [29]. Humans in contact with livestock, mostly pigs, could be temporarily infected with these strains, suggesting a zoonotic transmission [30]; however, those clones represented little pathogenicity for humans in general [31].
There is no doubt that AMR is one of the most dangerous threats to public health in the world and it seems that the Arab countries present an ideal environment for the spread of resistant strains [31][32]. This could be related to several reasons, including the over/misuse of antibiotics in humans and animals, and the high mobility of animals and herders in some countries. Next to that, by large, infection control measures are absent. From a sociological standpoint, the continuous population mobilization due to socioeconomic conflicts and multiple war crises are to be taken into account [33][34]. Other factors involved may be the specific environmental conditions, with large deserts and limited places with water where people cluster together with their animals, as well as the intensification of animal production [35]. These specific regional characteristics may have a relevant impact on the epidemiology of MRS. The problem with methicillin resistance in staphylococci in the Arab countries, as in other parts of the world, has grown steadily [36]. However, its extent is currently not clear since surveillance of drug resistance is only carried out in a few Arab countries [34][37].

References

  1. Search Result. Available online: https://lpsn.dsmz.de/search?word=staphylococcus (accessed on 15 May 2022).
  2. Madhaiyan, M.; Wirth, J.S.; Saravanan, V.S. Phylogenomic analyses of the Staphylococcaceae family suggest the reclassification of five species within the genus Staphylococcus as heterotypic synonyms, the promotion of five subspecies to novel species, the taxonomic reassignment of five Staphylococcus species to Mammaliicoccus gen. nov., and the formal assignment of Nosocomiicoccus to the family Staphylococcaceae. Int. J. Syst. Evol. Microbiol. 2020, 70, 5926–5936.
  3. Leroy, S.; Vermassen, A.; Talon, R. Staphylococcus: Occurrence and Properties. In 1st Encyclopedia of Food and Health; Elsevier: London, UK, 2015.
  4. Crossley, K.B.; Jefferson, K.K.; Archer, G.L.; Fowler, V.G. Staphylococci in Human Disease, 2nd ed.; Blackwell Publishing Ltd.: Hoboken, NJ, USA, 2009; pp. 1–623.
  5. Bose, J.L. Genetic manipulation of staphylococci. Methods Mol. Biol. 2014, 1106, 101–111.
  6. Becker, K.; Schaumburg, F.; Kearns, A.; Larsen, A.R.; Lindsay, J.A.; Skov, R.L.; Westh, H. Implications of identifying the recently defined members of the Staphylococcus aureus complex S. argenteus and S. schweitzeri: A position paper of members of the ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS). Clin. Microbiol. Infect. 2019, 25, 1064–1070.
  7. Vanderhaeghen, W.; Piepers, S.; Leroy, F.; Van Coillie, E.; Haesebrouck, F.; De Vliegher, S. Identification, typing, ecology and epidemiology of coagulase negative staphylococci associated with ruminants. Vet. J. 2015, 203, 44–51.
  8. Foster, T. Staphylococcus, 4th ed.; Medical Microbiology; University of Texas Medical Branch: Galveston, TX, USA, 1996; Chapter 12.
  9. Zondervan, N.A.; Martins Dos Santos, V.A.P.; Suarez-Diez, M.; Saccenti, E. Correction to: Phenotype and multi-omics comparison of Staphylococcus and Streptococcus uncovers pathogenic traits and predicts zoonotic potential. BMC Genom. 2021, 22, 384.
  10. Prestinaci, F.; Pezzotti, P.; Pantosti, A. Antimicrobial resistance: A global multifaceted phenomenon. Pathog. Glob. Health 2015, 109, 309–318.
  11. Boucher, H.; Miller, L.G.; Razonable, R.R. Serious infections caused by methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 2010, 51, 183–197.
  12. Jevons, M.P.; Coe, A.W.; Parker, M.T. Methicillin resistance in staphylococci. Lancet 1963, 1, 904–907.
  13. Itou, T.; Katayama, Y.; Hiramatsu, K. A new mobile genetic element, staphylococcal cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Nihon. Saikingaku. Zasshi. 2000, 55, 483–498. (In Japanese)
  14. Ben Chehida, F.; Gharsa, H.; Tombari, W.; Selmi, R.; Khaldi, S.; Daaloul, M.; Ben Slama, K.; Messadi, L. First Report of Antimicrobial Susceptibility and Virulence Gene Characterization Associated with Staphylococcus aureus Carriage in Healthy Camels from Tunisia. Animals 2021, 11, 2754.
  15. Nemeghaire, S.; Vanderhaeghen, W.; Argudín, M.A.; Haesebrouck, F.; Butaye, P. Characterization of methicillin-resistant Staphylococcus sciuri isolates from industrially raised pigs, cattle and broiler chickens. J. Antimicrob. Chemother. 2014, 69, 2928–2934.
  16. Schnitt, A.; Lienen, T.; Wichmann-Schauer, H.; Tenhagen, B.A. The occurrence of methicillin-resistant non-aureus staphylococci in samples from cows, young stock, and the environment on German dairy farms. J. Dairy Sci. 2021, 104, 4604–4614.
  17. Vanderhaeghen, W.; Vandendriessche, S.; Crombé, F.; Nemeghaire, S.; Dispas, M.; Denis, O.; Hermans, K.; Haesebrouck, F.; Butaye, P. Characterization of methicillin-resistant non-Staphylococcus aureus staphylococci carriage isolates from different bovine populations. J. Antimicrob. Chemother. 2013, 68, 300–307.
  18. Silva, F.R.; Mattos, E.M.; Coimbra, M.V.; Ferreira-Carvalho, B.T.; Figueiredo, A.M. Isolation and molecular characterization of methicillin-resistant coagulase-negative staphylococci from nasal flora of healthy humans at three community institutions in Rio de Janeiro City. Epidemiol. Infect. 2001, 127, 57–62.
  19. Kolappaswamy, K.; Shipley, S.T.; Tatarov, I.I.; DeTolla, L.J. Methicillin-resistant Staphylococcus non-aureus infection in an irradiated rhesus macaque (Macaca mulatta). J. Am. Assoc. Lab. Anim. Sci. 2008, 47, 64–67.
  20. Hanssen, A.M.; Ericson Sollid, J.U. SCCmec in staphylococci: Genes on the move. FEMS. Immunol. Med. Microbiol. 2006, 46, 8–20.
  21. Haag, A.F.; Fitzgerald, J.R.; Penadés, J.R. Staphylococcus aureus in Animals. Microbiol. Spectr. 2019, 7, 1–19.
  22. From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus—Minnesota and North Dakota, 1997–1999. JAMA 1999, 282, 1123–1125.
  23. Chambers, H.F. The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis. 2001, 7, 178–182.
  24. Simons, H.; Alcabes, P. A model for surveillance of methicillin-resistant Staphylococcus aureus. Public. Health Rep. 2008, 123, 21–29.
  25. Bukharie, H.A. A review of community-acquired methicillin-resistant Staphylococcus aureus for primary care physicians. J. Fam. Community Med. 2010, 17, 117–120.
  26. Voss, A.; Loeffen, F.; Bakker, J.; Klaassen, C.; Wulf, M. Methicillin-resistant Staphylococcus aureus in pig farming. Emerg. Infect. Dis. 2005, 11, 1965–1966.
  27. Denis, O.; Suetens, C.; Hallin, M.; Catry, B.; Ramboer, I.; Dispas, M.; Willems, G.; Gordts, B.; Butaye, P.; Struelens, M.J. Methicillin-resistant Staphylococcus aureus ST398 in swine farm personnel, Belgium. Emerg. Infect. Dis. 2009, 15, 1098–1101.
  28. Price, L.B.; Stegger, M.; Hasman, H.; Aziz, M.; Larsen, J.; Andersen, P.S.; Pearson, T.; Waters, A.E.; Foster, J.T.; Schupp, J.; et al. Staphylococcus aureus CC398: Host adaptation and emergence of methicillin resistance in livestock. mBio 2012, 3, e00305-11.
  29. Butaye, P.; Argudín, M.A.; Smith, T.C. Livestock-Associated MRSA and Its Current Evolution. Curr. Clin. Micro. Rpt. 2016, 3, 19–31.
  30. Berglund, C.; Söderquist, B. The origin of a methicillin-resistant Staphylococcus aureus isolate at a neonatal ward in Sweden-possible horizontal transfer of a staphylococcal cassette chromosome mec between methicillin-resistant Staphylococcus haemolyticus and Staphylococcus aureus. Clin. Microbiol. Infect. 2008, 14, 1048–1056.
  31. Springer, B.; Orendi, U.; Much, P.; Höger, G.; Ruppitsch, W.; Krziwanek, K.; Metz-Gercek, S.; Mittermayer, H. Methicillin-resistant Staphylococcus aureus: A new zoonotic agent? Wien. Klin. Wochenschr. 2009, 121, 86–90.
  32. WHO. Global Antimicrobial Resistance Surveillance System (GLASS) Report. 2017. Available online: http://www.who.int/glass/resources/publications/early-implementation-report/en/ (accessed on 25 January 2022).
  33. Rizk, N.A.; Moghnieh, R.; Haddad, N.; Rebeiz, M.C.; Zeenny, R.M.; Hindy, J.R.; Orlando, G.; Kanj, S.S. Challenges to Antimicrobial Stewardship in the Countries of the Arab League: Concerns of Worsening Resistance during the COVID-19 Pandemic and Proposed Solutions. Antibiotics 2021, 10, 1320.
  34. Ballouz, T.; Rizk, N.; Kanj, S.S. Antimicrobial Resistance in the Arab Region. In Handbook of Healthcare in the Arab World; Laher, I., Ed.; Springer: Cham, Switzerland, 2019.
  35. Wall, B.A.; Mateus, A.L.P.; Marshall, L.; Pfeiffer, D.U.; Lubroth, J.; Ormel, H.J.; Otto, P.; Patriarchi, A. Drivers, Dynamics and Epidemiology of Antimicrobial Resistance in Animal Production; FAO: Rome, Italy, 2016. Available online: http://www.fao.org/3/a-i6209e.pdf (accessed on 14 January 2022).
  36. Ventola, C.L. The antibiotic resistance crisis: Part 1: Causes and threats. Pharm. Ther. 2015, 40, 277–283.
  37. Moghnieh, R.A.; Kanafani, Z.A.; Tabaja, H.Z.; Sharara, S.L.; Awad, L.S.; Kanj, S.S. Epidemiology of common resistant bacterial pathogens in the countries of the Arab League. Lancet Infect. Dis. 2018, 18, 379–394.
More
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 535
Revisions: 2 times (View History)
Update Date: 15 Jul 2022
1000/1000